Who Supplies Famotidine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Famotidine exports, with 152+ registered manufacturers shipping to buyers across 66+ countries — yet a handful of companies dominate the shipments. ANNORA PHARMA PRIVATE LIMITED holds the largest share at 11.6% (export value: $6.5M). Close behind, VKT PHARMA PRIVATE LIMITED (11.4%, $6.4M). MYLAN LABORATORIES LIMITED (7.8%, $4.4M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Famotidine? Top Manufacturers & Their Buyers
Flow of Famotidine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Famotidine Supplier Network — Key Market Intelligence
The Famotidine export market from India is led by ANNORA PHARMA PRIVATE LIMITED, which alone commands a 11.6% share, shipping $6.5M worth of product across 435 shipments. The second-largest exporter, VKT PHARMA PRIVATE LIMITED, contributes $6.4M (11.4%) to the overall market. Combined, the top two suppliers alone account for 23.0% of all Famotidine exports, indicating a relatively concentrated supply base.
Across all 152 tracked manufacturers, the total Famotidine export value stands at $55.8M from 2.8K shipments. The market average shipment value is $20.3K. The single largest buyer relationship in terms of trade value is J. KNIPPER & COMPANY, receiving $2.6M worth of product.
The combined buyer network spans 11 named purchasing companies, including CAMBER PHARMACEUTICALS INC, M/S., M S ASCEND LABORATORIES LLC, GLENMARK THERAPEUTICS INC., USA, ASCEND LABORATORIES LLC and 6 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ANNORA PHARMA PRIVATE LIMITED
ANNORA PHARMA PRIVATE LIMITED is the first-largest Famotidine exporter from India, with a market share of 11.6% and a total export value of $6.5M across 435 shipments. Their average shipment value of $14.9K is below the market average of $20.3K, reflecting a high-volume, competitive pricing strategy.
ANNORA PHARMA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF. — $3.0M across 203 shipments (46.6% of this supplier's total exports)
• TO THE ORDER OF. — $1.9M across 128 shipments (29.4% of this supplier's total exports)
• CAMBER PHARMACEUTICALS INC — $774.1K across 52 shipments (11.9% of this supplier's total exports)
• TO THE ORDER — $599.3K across 40 shipments (9.2% of this supplier's total exports)
• M/S. — $186.2K across 12 shipments (2.9% of this supplier's total exports)
Key Insight: ANNORA PHARMA PRIVATE LIMITED operates with high shipment frequency (435 shipments) at a per-shipment value of $14.9K, indicating a broad distribution network with many smaller, regular orders.
2VKT PHARMA PRIVATE LIMITED
VKT PHARMA PRIVATE LIMITED is the second-largest Famotidine exporter from India, with a market share of 11.4% and a total export value of $6.4M across 173 shipments. Their average shipment value of $36.8K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
VKT PHARMA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• M S ASCEND LABORATORIES LLC — $2.2M across 59 shipments (33.9% of this supplier's total exports)
• TO THE ORDER — $1.8M across 50 shipments (28.9% of this supplier's total exports)
• GLENMARK THERAPEUTICS INC., USA — $1.1M across 30 shipments (17.3% of this supplier's total exports)
• TO THE ORDER — $841.1K across 23 shipments (13.2% of this supplier's total exports)
• ASCEND LABORATORIES LLC — $422.6K across 11 shipments (6.6% of this supplier's total exports)
Key Insight: VKT PHARMA PRIVATE LIMITED's per-shipment value of $36.8K is 81% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
3MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the third-largest Famotidine exporter from India, with a market share of 7.8% and a total export value of $4.4M across 212 shipments. Their average shipment value of $20.7K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 2 named buyers in our database. MYLAN INSTITUTIONAL INC is the dominant customer, accounting for 58.0% of this supplier's tracked business. Top customers include:
• MYLAN INSTITUTIONAL INC — $2.5M across 123 shipments (58.0% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC — $1.8M across 89 shipments (42.0% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $20.7K is 2% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
4ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the fourth-largest Famotidine exporter from India, with a market share of 7.5% and a total export value of $4.2M across 124 shipments. Their average shipment value of $33.6K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. J. KNIPPER & COMPANY is the dominant customer, accounting for 63.2% of this supplier's tracked business. Top customers include:
• J. KNIPPER & COMPANY — $2.6M across 78 shipments (63.2% of this supplier's total exports)
• J. KNIPPER & COMPANY — $560.9K across 17 shipments (13.5% of this supplier's total exports)
• J. KNIPPER & COMPANY — $544.7K across 16 shipments (13.1% of this supplier's total exports)
• J. KNIPPER & COMPANY — $336.9K across 10 shipments (8.1% of this supplier's total exports)
• J. KNIPPER & COMPANY — $89.0K across 3 shipments (2.1% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $33.6K is 66% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
5APOTHECON PHARMACEUTICALS PRIVATE LIMITED
APOTHECON PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Famotidine exporter from India, with a market share of 3.4% and a total export value of $1.9M across 31 shipments. Their average shipment value of $61.1K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
APOTHECON PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. TO THE ORDER OF NAVI is the dominant customer, accounting for 80.7% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF NAVI — $1.5M across 25 shipments (80.7% of this supplier's total exports)
• To The Order — $344.7K across 6 shipments (18.2% of this supplier's total exports)
• QOMEL CO LTD — $14.1K across 0 shipments (0.7% of this supplier's total exports)
• QOMEL CO LTD — $7.3K across 0 shipments (0.4% of this supplier's total exports)
• DAW KYI THANT SYN — $25 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: APOTHECON PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $61.1K is 201% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
6MEDREICH LIMITED
MEDREICH LIMITED is the fifth-largest Famotidine exporter from India, with a market share of 3.3% and a total export value of $1.8M across 23 shipments. Their average shipment value of $80.3K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
MEDREICH LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MEIJI SEIKA PHARMATECH CO., LTD — $762.3K across 9 shipments (41.3% of this supplier's total exports)
• MEIJI SEIKA PHARMATECH CO., LTD — $604.9K across 8 shipments (32.7% of this supplier's total exports)
• MEIJI SEIKA PHARMA C — $289.4K across 4 shipments (15.7% of this supplier's total exports)
• MEIJI SEIKA PHARMATECH CO., LTD — $191.0K across 2 shipments (10.3% of this supplier's total exports)
Key Insight: MEDREICH LIMITED's per-shipment value of $80.3K is 296% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Famotidine Flows
Once Famotidine leaves the manufacturing plants of companies like ANNORA PHARMA PRIVATE LIMITED and VKT PHARMA PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $55.8M. United States absorbs the largest share at 84.0% ($46.8M), followed by Japan (4.4%) and Sri Lanka (3.5%).
In United States — the top destination — named importers include MYLAN INSTITUTIONAL INC 2898, J. KNIPPER & COMPANY, MYLAN INSTITUTIONAL INC. In Japan, key buyers are MEIJI SEIKA PHARMATECH CO., LTD.
This geographic spread reflects Famotidine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Famotidine Go? Top Importing Countries & Their Buyers
Trade flow of Famotidine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Famotidine imports from India, with a total trade value of $46.8M across 546 shipments — representing a 84.0% share of all Famotidine exports. The average shipment value of $85.8K is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations. This market is served by 12 tracked buyers.
Named Famotidine importers in United States: MYLAN INSTITUTIONAL INC 2898 is the largest buyer, accounting for 10.6% ($5.0M) of this market's total imports.
• MYLAN INSTITUTIONAL INC 2898 — $5.0M (10.6% of United States's total)
• J. KNIPPER & COMPANY — $3.2M (6.9% of United States's total)
• MYLAN INSTITUTIONAL INC — $2.6M (5.5% of United States's total)
Key Insight: United States's per-shipment average of $85.8K (323% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Famotidine imports from India.
2Japan
Japan ranks as the second-largest destination for Famotidine imports from India, with a total trade value of $2.4M across 12 shipments — representing a 4.4% share of all Famotidine exports. The average shipment value of $202.8K is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Famotidine importers in Japan: MEIJI SEIKA PHARMATECH CO., LTD is the largest buyer, accounting for 31.3% ($762.3K) of this market's total imports.
• MEIJI SEIKA PHARMATECH CO., LTD — $762.3K (31.3% of Japan's total)
Key Insight: Japan's per-shipment average of $202.8K (899% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Japan is a key market for Famotidine imports from India.
3Sri Lanka
Sri Lanka ranks as the third-largest destination for Famotidine imports from India, with a total trade value of $1.9M across 0 shipments — representing a 3.5% share of all Famotidine exports. The average shipment value of $1.9M is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Sri Lanka's per-shipment average of $1.9M (9493% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Famotidine imports from India.
4Canada
Canada ranks as the fourth-largest destination for Famotidine imports from India, with a total trade value of $719.2K across 0 shipments — representing a 1.3% share of all Famotidine exports. The average shipment value of $719.2K is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Canada's per-shipment average of $719.2K (3445% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Famotidine imports from India.
5Costa Rica
Costa Rica ranks as the fifth-largest destination for Famotidine imports from India, with a total trade value of $702.9K across 0 shipments — representing a 1.3% share of all Famotidine exports. The average shipment value of $702.9K is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Costa Rica's per-shipment average of $702.9K (3364% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Costa Rica is a key market for Famotidine imports from India.
People Also Ask — Famotidine Supplier & Trade Network
Who are the top suppliers of Famotidine from India?+
Which companies buy Famotidine from Indian manufacturers?+
Where does Famotidine exported from India go?+
What is the market share of the top Famotidine supplier from India?+
What is the average shipment value for Famotidine exports from India?+
Is Famotidine manufactured in India and exported globally?+
Which country imports the most Famotidine from India?+
Who are the buyers of Famotidine in Japan?+
How concentrated is the Famotidine supplier market in India?+
How do I find verified buyers for Famotidine in specific countries?+
Famotidine Trade Network — Key Takeaways
- 1ANNORA PHARMA PRIVATE LIMITED is India's dominant Famotidine exporter with a 11.6% market share and $6.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 152 suppliers collectively account for 45.1% of all tracked Famotidine exports, with a combined trade value of $55.8M.
- 3United States is the largest destination market, absorbing 84.0% of India's Famotidine exports ($46.8M). Japan (4.4%) and Sri Lanka (3.5%) follow.
- 4With 2.8K total shipments averaging $20.3K each, the Famotidine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CAMBER PHARMACEUTICALS INC, M/S., M S ASCEND LABORATORIES LLC, GLENMARK THERAPEUTICS INC., USA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 66 countries
Network value: $55.8M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Famotidine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Famotidine.
- 2.Flow Mapping: 152 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,750 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 66 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,750 Verified Shipments
152 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists